Literature DB >> 8818879

Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices.

P R Hsueh1, L J Teng, S W Ho, W C Hsieh, K T Luh.   

Abstract

Clinical infections caused by Flavobacterium indologenes have never been documented. Thirteen isolates derived from seven patients with indwelling device-associated F. indologenes infections were identified from 1 April through 30 November 1995. The antimicrobial susceptibilities to 20 antimicrobial agents of the isolates, the cellular fatty acid chromatograms for the isolates, and the random amplified polymorphic DNA (RAPD) patterns generated by arbitrarily primed PCR of the isolates were studied. The antibiotypes and RAPD patterns differed among the isolates recovered from different patients. However, both antibiotypes and RAPD patterns were identical among the five isolates from one patient with multiple episodes of central venous catheter-associated bacteremia within a 1.5-month period and between the two isolates from another patient suffering from two episodes of catheter-related bacteriuria at an interval of 14 days. It is documented that the recurrent infections in each of these two patients were caused by a single F. indologenes clone, respectively. Identical antibiotypes and RAPD patterns were also demonstrated between two isolates from a patient with ventilator-associated pneumonia, one recovered from an endotracheal aspirate and the other derived from a blood specimen 10 days later, indicating the invasive nature of F. indologenes. Two cellular fatty acid chromatograms were identified among these isolates. All of the isolates showed in vitro resistance to cephalothin, cefotaxime, ceftriaxone, moxalactam, aztreonam, aminoglycosides, erythromycin, clindamycin, vancomycin, and teicoplanin. F. indologenes should be included as an etiologic agent of infections associated with the use of indwelling devices.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818879      PMCID: PMC229151          DOI: 10.1128/jcm.34.8.1908-1913.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment.

Authors:  R M GEORGE; C P COCHRAN; W E WHEELER
Journal:  Am J Dis Child       Date:  1961-03

Review 2.  Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

4.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

5.  Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections.

Authors:  Y Siegman-Igra; D Schwartz; G Soferman; N Konforti
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species.

Authors:  W E Stamm; J J Colella; R L Anderson; R E Dixon
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

7.  Cellular fatty acids of Flavobacterium meningosepticum and Flavobacterium species group IIb.

Authors:  C W Moss; S B Dees
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

8.  Central venous catheter-related infections in pediatric hematology-oncology patients: role of home and hospital management.

Authors:  C Rizzari; G Palamone; A Corbetta; C Uderzo; E F Viganò; G Codecasa
Journal:  Pediatr Hematol Oncol       Date:  1992 Apr-Jun       Impact factor: 1.969

9.  Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al 1984.

Authors:  E Yabuuchi; Y Hashimoto; T Ezaki; Y Ido; N Takeuchi
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

10.  Chemical characterization of Flavobacterium odoratum, Flavobacterium breve, and Flavobacterium-like groups IIe, IIh, and IIf.

Authors:  S B Dees; C W Moss; D G Hollis; R E Weaver
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

View more
  35 in total

1.  Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 3.267

2.  Chryseobacterium indologenes catheter-related meningitis in an elderly patient after intracranial aneurysm clipping surgery.

Authors:  Xiaoliang Wang; Zhigang Hu; Youwu Fan; Handong Wang
Journal:  Neurol Sci       Date:  2013-07-17       Impact factor: 3.307

3.  Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.

Authors:  George B Christakis; Stavroula P Perlorentzou; Irene Chalkiopoulou; Athanasios Athanasiou; Nikolas J Legakis
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 4.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

5.  Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates.

Authors:  P R Hsueh; J C Chang; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  PCR assay for species-specific identification of Bacteroides thetaiotaomicron.

Authors:  L J Teng; P R Hsueh; J C Tsai; F L Chiang; C Y Chen; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

7.  Recurrent infections and chronic colonization by an Escherichia coli clone in the respiratory tract of a patient with severe cystic bronchiectasis.

Authors:  J Y Wang; P R Hsueh; J T Wang; L N Lee; P C Yang; K T Luh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.

Authors:  J C Chang; P R Hsueh; J J Wu; S W Ho; W C Hsieh; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

9.  Dissemination of two methicillin-resistant Staphylococcus aureus clones exhibiting negative staphylase reactions in intensive care units.

Authors:  P R Hsueh; L J Teng; P C Yang; H J Pan; Y C Chen; L H Wang; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Chryseobacterium indologenes central nervous system infection in infancy: an emergent pathogen?

Authors:  P Olbrich; M Rivero-Garvía; M D Falcón-Neyra; J A Lepe; J M Cisneros; J Marquez-Rivas; O Neth
Journal:  Infection       Date:  2013-05-25       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.